MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $32,000 | -59.5% | 25,600 | 0.0% | 0.00% | -60.0% |
| Q1 2017 | $79,000 | -24.0% | 25,600 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $104,000 | -36.2% | 25,600 | 0.0% | 0.01% | -36.4% |
| Q3 2016 | $163,000 | -23.8% | 25,600 | 0.0% | 0.02% | -26.7% |
| Q1 2016 | $214,000 | +5.9% | 25,600 | 0.0% | 0.03% | +3.4% |
| Q4 2015 | $202,000 | -7.3% | 25,600 | 0.0% | 0.03% | -12.1% |
| Q3 2015 | $218,000 | -31.2% | 25,600 | 0.0% | 0.03% | -10.8% |
| Q2 2015 | $317,000 | +4.3% | 25,600 | 0.0% | 0.04% | 0.0% |
| Q1 2015 | $304,000 | +5.2% | 25,600 | 0.0% | 0.04% | -15.9% |
| Q4 2014 | $289,000 | +28.4% | 25,600 | 0.0% | 0.04% | +25.7% |
| Q3 2014 | $225,000 | +20.3% | 25,600 | 0.0% | 0.04% | +20.7% |
| Q2 2014 | $187,000 | +45.0% | 25,600 | 0.0% | 0.03% | +38.1% |
| Q1 2014 | $129,000 | -5.1% | 25,600 | 0.0% | 0.02% | -4.5% |
| Q4 2013 | $136,000 | +40.2% | 25,600 | 0.0% | 0.02% | +15.8% |
| Q3 2013 | $97,000 | -43.9% | 25,600 | 0.0% | 0.02% | -38.7% |
| Q2 2013 | $173,000 | – | 25,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|